Preclinical • Combination therapy
|
EGFR (Epidermal growth factor receptor) • MET (MET proto-oncogene, receptor tyrosine kinase)
|
EGFR mutation • EGFR exon 19 deletion • MET amplification • EGFR T790M • MET mutation • MET amplification + EGFR mutation
|
Tagrisso (osimertinib) • gefitinib • Leclaza (lazertinib) • babamekip (ABN401)